irAE-GPT: leveraging large language models to identify immune-related adverse events in electronic health records and clinical trial datasets

By afschroeder • April 9, 2026

Bejan CA, Wang M, Venkateswaran S, Bergmann EA, Hiles L, Xu Y, Chandler GS, Brondfield S, Silverstein J, Wright F, de Dios K, Kim DM, Mukherjee E, Krantz MS, Yao L, Johnson DB, Phillips EJ, Balko JM, Mohindra R, Quandt Z. irAE-GPT: leveraging large language models to identify immune-related adverse events in electronic health records and clinical trial datasets. EBioMedicine. 2026 Apr 7:106227. doi: 10.1016/j.ebiom.2026.106227. Epub ahead of print. PMID: 41951517.

Tags: clinical trials, Electronic health records, Generative artificial intelligence, Hematology/Oncology, immune-related adverse events, Large language models, Publications

Durvalumab plus etoposide-platinum in patients with epidermal growth factor receptor (EGFR)-mutated advanced NSCLC and neuroendocrine transformation after first-line osimertinib: ORCHARD

Okamoto I, Cho BC, Goldberg SB, Goldman JW, de Langen AJ, Piotrowska Z, Riess JW, Yu HA, Garcia Campelo MR, Cetnar J, Kim YJ, Novello[...]

Redefining therapeutic horizons in thymic epithelial tumors: precision, combinations, and emerging biology

Marks JA, Maniar R, Ramchandran KJ, Pietroluongo E, Altan M, Singhal S, Aldea M, Goldman JW, Reiss JW, Wakelee H, Loehrer PJ, Chiara Garassino M,[...]

Genotoxic antibody-drug conjugates combined with BCL-XL inhibitors enhance therapeutic efficacy in metastatic castration-resistant prostate cancer

Semenova G, Frank SB, Dumpit R, Han W, Coleman I, Gulati R, Dirican CD, Arman T, Maruwan J, Morrissey C, Haffner MC, Nelson PS, Lee[...]